Texas Attorney General Ken Paxton is coming after Medicaid fraudsters — and he’s got new federal data to do it with. The state’s Healthcare Program Enforcement Division has launched investigations into dozens of providers across Texas, armed with claims data that only became available after the Department of Government Efficiency made it public earlier this year.
The move marks a significant escalation in Texas’s ongoing war on Medicaid abuse. Paxton’s office confirmed the new wave of investigations targets home health providers, occupational therapy providers, and entities suspected of exploiting COVID-19 treatment programs for financial gain. The effort is being fueled, in part, by HHS Medicaid data that DOGE released and publicized on X — framing it explicitly as a tool to root out fraud at the federal level. Texas, it turns out, was paying close attention.
A New Data Pipeline, A New Wave of Cases
It’s not every day a state attorney general gets a fresh trove of federal claims data dropped in his lap. But that’s essentially what happened here. Investigators will cross-reference DOGE’s released data against the OAG’s own internal claims database, and they’ll deploy Civil Investigative Demands — a powerful legal instrument — as they build toward potential litigation. The combination gives prosecutors a broader, more detailed picture of billing patterns than they’ve previously had access to.
Paxton didn’t mince words about the stakes. “Unlike states that are run by radical left-wing lunatics, we will not tolerate the abuse of taxpayer funded programs in Texas,” he said in a statement. “My office has already recovered over $1 billion from Medicaid fraud alone since 2020, and I will continue to pursue any fraudster who attempts to cheat Texans out of money by exploiting our healthcare system.” Whatever one makes of the rhetoric, the underlying enforcement record is hard to dismiss.
Beyond the New Investigations
So what has the Healthcare Program Enforcement Division actually been up to? Quite a lot, it turns out. The division has filed a string of high-profile cases in recent months that go well beyond routine billing disputes. Among the most closely watched: a lawsuit against Children’s Health and a Dallas-area physician over gender transition procedures performed on minors — a politically charged case that fits squarely within Paxton’s broader policy agenda.
But there’s more in the docket that’s harder to frame as purely ideological. The OAG has also sued a dental network accused of defrauding Texas Medicaid, and taken on pharmaceutical heavyweights Sanofi and Eli Lilly over alleged illegal kickbacks to doctors. A separate action targets Sanofi and Bristol-Myers Squibb for allegedly failing to disclose that the blockbuster blood thinner Plavix is ineffective in certain patient populations — a public health allegation with potentially wide-ranging consequences.
Then there’s the $41.5 million settlement secured from Pfizer and Tris Pharma over claims that the companies provided adulterated drugs to children. That one, notably, drew less partisan fanfare — but may be among the most consequential outcomes the division has produced.
What This Signals Going Forward
That’s the catch, really. The new investigations leveraging DOGE data represent something of a test case for whether federal data-sharing initiatives can meaningfully supercharge state-level enforcement — or whether the whole exercise is more about optics than outcomes. The answer will likely come out in court filings over the next year or two, as Civil Investigative Demands turn into lawsuits and lawsuits turn into settlements, or don’t.
Still, a billion dollars recovered in roughly five years is not nothing. And the pipeline of new cases — spanning pharmaceutical giants, dental networks, and home health providers — suggests Paxton’s enforcement shop isn’t slowing down. Whether the DOGE data proves to be a genuine investigative breakthrough, or simply adds velocity to cases that would’ve been built anyway, remains to be seen.
For the providers now under the microscope, the message is fairly clear: Texas has more data than it used to, more cases than it had last year, and an attorney general who’s made Medicaid enforcement a centerpiece of his tenure. That’s not a combination most defense attorneys would relish walking into.
